grabeng veins 'yan. 😭😭 as a medtech na pasmado ang kamay, di ko masyado bet mag-venipuncture, pero sige na, para sa'yo madam, ako na mag-e-extract ng dugo 🫠

one call from Trump and all those Chinese medical robots will have zero international customers But truth is, Trump wants low healthcare so will pretend he's protecting US Medtech/Biotech but will let China biotech/medtech grow to put pressure on prices or get a stake

baka need niyo ng medtech reliever diyan, pangdagdag funds sa jhhj unit debut 😇

we crossed 550k arr about six months in. 40-something clients across seven segments that look nothing alike. medtech, industrials, insurance, travel, saas. i kept waiting for the playbook to break between them and it mostly doesn't. a health brand and a mittelstand machine builder have the same core problem: real product, real demand, and an AI that can't describe them when a buyer asks. the industry changes, the fix doesn't. that's the part that made me believe this was a company and not a service.

GOOD EVE, LF COMMISSIONER? 🩷 client essay paper ppt report analysis drawing infographic anaphy chemistry biochem hematology clinical pmtp histo med comms mtlbe cc medtech case study cyto immuno serology bloodbank bacte aubf parasitology microscopy mycology virology health

$PODD (Insulet) PODD is no longer just an insulin pump company. It's increasingly being viewed as a diabetes technology leader, with strong recurring revenue and long-term growth driven by the global adoption of automated insulin delivery systems. Outlook: Bullish. Key drivers: • Continued Omnipod adoption • Expanding international markets • Recurring consumables revenue • Innovation in diabetes management Risks: • Competitive diabetes device market • Reimbursement pressure • Product execution risk Trading framework: • Support: Previous breakout level • Accumulation zone: Pullbacks toward trend support • Breakout trigger: New all-time highs with above-average volume • Risk control: Below major support Core view: PODD is a medtech growth story built around: diabetes innovation recurring revenue global expansion If you want to stay up to date on the latest market trends and stock information, please follow me and give this post a like. 👉If you'd like to stay updated on the latest market trends and stock sales information, please add me as a WhatsApp friend via the link on my profile page. I'll share my unique market insights with you in my private group. #PODD #StockMarket #WallStreet #Healthcare #MedTech #GrowthStocks

$RXST (RxSight) RXST is no longer just a medical technology company. It's increasingly being viewed as a leader in next-generation cataract treatment, powered by its proprietary Light Adjustable Lens platform. Outlook: Bullish. Key drivers: • Strong adoption of Light Adjustable Lens • Growing cataract procedure volume • Expanding surgeon network • High-margin recurring revenue opportunity Risks: • Competitive ophthalmology market • Slower adoption by surgeons • Execution risk Trading framework: • Support: Previous consolidation zone • Accumulation zone: Pullbacks above trend support • Breakout trigger: New highs backed by strong volume • Risk control: Below key support Core view: RXST is a medtech growth story built around: premium technology procedure growth recurring revenue If you want to stay up to date on the latest market trends and stock information, please follow me and give this post a like. 👉If you'd like to stay updated on the latest market trends and stock sales information, please add me as a WhatsApp friend via the link on my profile page. I'll share my unique market insights with you in my private group. #RXST #StockMarket #WallStreet #Healthcare #MedTech #Bullish

sana po matuloy po si medtech po

𝐒𝐨𝐦𝐞𝐭𝐡𝐢𝐧𝐠 𝐛𝐢𝐠 𝐢𝐬 𝐨𝐧 𝐭𝐡𝐞 𝐰𝐚𝐲... One licence. Five award nominations. Two new doctors. Countless stories of innovation. The 𝐔𝐂𝐓 𝐌𝐞𝐝𝐓𝐞𝐜𝐡 𝐖𝐢𝐧𝐭𝐞𝐫 𝐍𝐞𝐰𝐬𝐥𝐞𝐭𝐭𝐞𝐫 – 𝐕𝐨𝐥𝐮𝐦𝐞 𝟐, 𝐈𝐬𝐬𝐮𝐞 𝟏 arrives this Thursday. Inside, you'll discover international collaborations, student achievements, research breakthroughs, regulatory milestones, awards, and the people advancing biomedical engineering in South Africa and beyond. Designed here. Built here. Shared with the world. 👀 Watch this space. #UCTMedTech #BMERC #BiomedicalEngineering #MedTechAfrica #InnovationInHealthcare #ResearchExcellence @SudeshSivarasu @UCT_news @NRF_News @UCTHealthSci @dstigovza

@Intervoke_Media brings complex medical tech to life with this stunning new 3D MOA animation developed with @LivaNova, detailing Proximal Hypoglossal Nerve Stimulation (PHGNS). Explore more: medillsb.com/artist.aspx?AID… #intervoke #livanova #medicalanimation #3danimation #medtech

Millions of people around the world are affected by keratoconus, a progressive eye disorder where the cornea thins and bulges outwards. In severe cases, a corneal transplant may be the only treatment option; however, there is a limited supply of donor tissue. The Augel project is set to change this. ETH Pioneer Fellow Shuo Li is developing a soft hydrogel implant to stabilise the cornea and improve vision. The implant can be manufactured entirely in the lab, is cost-effective and can be integrated with existing laser surgery methods. Initial tests in the laboratory and in animal models have yielded promising results. The next step is to initiate the first human clinical study of the method. Video: Nicole Davidson (video production), Helena Klein (animation) / ETH Zurich #engineering #technology #medtech #ethzurich

📌Save the date! On Aug 5, 2026, @MQCI_info celebrates its 1st Incorporation Day at @AP_MedTechZone ! Dive into a day of expert talks, masterclasses, and insights on #quality, #innovation, and trust in #MedTech. ✨Register now: bit.ly/3RiSOTl #MedTech #HealthTech

Consulting firms can stop paying the AI bill for their clients. When your team runs AI coding tools on a client project, that API usage disappears into your overhead. ❌ You can't invoice for it. ❌ You can't even see it broken out by client. GetWrangler sits in your LLM API path. ✅ Claude Code: full agent usage tracked and billable ✅ GitHub CoPilot - Full agent usage tracked and billable ✅ Codex CLI - Full agent usage tracked and billable ✅ Cursor: chat and planning mode tracked (full usage not permitted) It tracks usage per project, per client, per tool — then lets you bill it back. 👉 Built first for medtech software teams (application and embedded) doing contract development. Works the same for legal firms and any partner who bills clients by the hour. See how it works: GetWrangler.ai (Free trial - no CC required)

South Korea: Andhra Pradesh Minister Nara Lokesh meets Shoealls CEO to explore smart healthcare footwear and MedTech collaboration.

𝗪𝗵𝘆 𝗦𝗽𝗮𝗰𝗲, 𝗗𝗲𝗳𝗲𝗻𝘀𝗲 & 𝗠𝗲𝗱𝗧𝗲𝗰𝗵 𝗮𝗿𝗲 𝗜𝗻𝗱𝗶𝗮'𝘀 𝗡𝗲𝘅𝘁 𝗕𝗶𝗴 𝗚𝗿𝗼𝘄𝘁𝗵 𝗦𝗲𝗰𝘁𝗼𝗿𝘀? Dr. @shivkuma_k discusses why sectors such as space, defense, drones, robotics & medical technologies are becoming key drivers of India's innovation-led growth.

The Medical University of Graz enrolled the first patient in DEEPER CHALLENGE, an investigator-initiated study evaluating @reflowmedical's Spur Peripheral Retrievable Scaffold. 📰 Learn more: eu1.hubs.ly/H0wKdHK0 #MedTech #MedicalDevices #CLTI #ClinicalTrials